CenterWatch Announces May Release of “State of the Clinical Trials Industry”

Friday, April 17, 2009 08:00 AM

CenterWatch, a global source for clinical trials information, announced today the planned release of its fifth edition of the annual sourcebook, State of the Clinical Trials Industry, due out in late May.

With more than 645 charts and graphs, including 400 that are new or updated, State of the Clinical Trials Industry offers a detailed examination of the global clinical trials industry and provides proprietary charts and graphs from CenterWatch’s clinical research benchmarking surveys.

This year’s edition, the most comprehensive to date, reviews the challenges sponsors and CROs faced in 2008, the strong growth in the outsourcing sector, and the latest results from CenterWatch’s annual patient and physician surveys focused on volunteer experiences and physician referrals to clinical trials.

“Each year researchers, biotech and pharmaceutical executives, CRO executives, and investment analysts anticipate the release of the new edition,” said Mary Jo Lamberti, Ph.D., CenterWatch’s director of market research and editor of the book. “It is an invaluable resource for those seeking competitive intelligence and data analysis which provides insight into global industry trends.”
 
To reserve a copy of State of the Clinical Trials Industry, visit the CenterWatch bookstore at http://store.centerwatch.com.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs